# 22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA

> **NCT03903471** · NA · UNKNOWN · sponsor: **Jiayuan Sun** · enrollment: 600 (estimated)

## Conditions studied

- Lymph Node Disease

## Interventions

- **DEVICE:** 22G-ProCore Endobronchial Ultrasound Needle
- **DEVICE:** 22G-Standard Endobronchial Ultrasound Needle

## Key facts

- **NCT ID:** NCT03903471
- **Lead sponsor:** Jiayuan Sun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-08
- **Primary completion:** 2023-10-08
- **Final completion:** 2023-10-08
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903471, "22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03903471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*